BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28342872)

  • 41. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
    Niedenthal R
    Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is Transthyretin a Regulator of Ubc9 SUMOylation?
    Wieczorek E; Kędracka-Krok S; Sołtys K; Jankowska U; Hołubowicz R; Seliga J; Ożyhar A
    PLoS One; 2016; 11(8):e0160536. PubMed ID: 27501389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells.
    Huang CH; Yang TT; Lin KI
    J Biomed Sci; 2024 Jan; 31(1):16. PubMed ID: 38280996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins.
    Henderson LE; Sowder RC; Smythers GW; Oroszlan S
    J Virol; 1987 Apr; 61(4):1116-24. PubMed ID: 3029406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly.
    Puffer BA; Watkins SC; Montelaro RC
    J Virol; 1998 Dec; 72(12):10218-21. PubMed ID: 9811764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of the non-structural influenza A viral protein NS1A as a bona fide target of the Small Ubiquitin-like MOdifier by the use of dicistronic expression constructs.
    Pal S; Rosas JM; Rosas-Acosta G
    J Virol Methods; 2010 Feb; 163(2):498-504. PubMed ID: 19917317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of the Ebola Virus VP24 Protein by SUMO.
    Vidal S; El Motiam A; Seoane R; Preitakaite V; Bouzaher YH; Gómez-Medina S; San Martín C; Rodríguez D; Rejas MT; Baz-Martínez M; Barrio R; Sutherland JD; Rodríguez MS; Muñoz-Fontela C; Rivas C
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Noncovalent SUMO-interaction motifs in HIV integrase play important roles in SUMOylation, cofactor binding, and virus replication.
    Zheng Y; Jayappa KD; Ao Z; Qiu X; Su RC; Yao X
    Virol J; 2019 Apr; 16(1):42. PubMed ID: 30940169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. RWD Domain as an E2 (Ubc9)-Interaction Module.
    Alontaga AY; Ambaye ND; Li YJ; Vega R; Chen CH; Bzymek KP; Williams JC; Hu W; Chen Y
    J Biol Chem; 2015 Jul; 290(27):16550-9. PubMed ID: 25918163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late domain-dependent inhibition of equine infectious anemia virus budding.
    Shehu-Xhilaga M; Ablan S; Demirov DG; Chen C; Montelaro RC; Freed EO
    J Virol; 2004 Jan; 78(2):724-32. PubMed ID: 14694104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
    Hsieh YL; Kuo HY; Chang CC; Naik MT; Liao PH; Ho CC; Huang TC; Jeng JC; Hsu PH; Tsai MD; Huang TH; Shih HM
    EMBO J; 2013 Mar; 32(6):791-804. PubMed ID: 23395904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
    Dütting E; Schröder-Kress N; Sticht H; Enz R
    Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential effects of actin cytoskeleton dynamics on equine infectious anemia virus particle production.
    Chen C; Weisz OA; Stolz DB; Watkins SC; Montelaro RC
    J Virol; 2004 Jan; 78(2):882-91. PubMed ID: 14694119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Equine infectious anemia virus and the ubiquitin-proteasome system.
    Ott DE; Coren LV; Sowder RC; Adams J; Nagashima K; Schubert U
    J Virol; 2002 Mar; 76(6):3038-44. PubMed ID: 11861870
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
    Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
    Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Small ubiquitin-like modifier (SUMO) conjugation impedes transcriptional silencing by the polycomb group repressor Sex Comb on Midleg.
    Smith M; Mallin DR; Simon JA; Courey AJ
    J Biol Chem; 2011 Apr; 286(13):11391-400. PubMed ID: 21278366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis.
    Moschos SJ; Mo YY
    J Mol Histol; 2006 Sep; 37(5-7):309-19. PubMed ID: 16758298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1.
    Watanabe M; Itoh K
    Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of the protease gene of equine infectious anemia virus in Escherichia coli: formation of the mature processed enzyme and specific cleavage of the gag precursor.
    Rushlow K; Peng XX; Montelaro RC; Shih DS
    Virology; 1992 May; 188(1):396-401. PubMed ID: 1314466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.